To pay or not to pay? A decision cost-utility analysis of angiotensin-converting enzyme inhibitor therapy for diabetic nephropathy. - Clark,W.; Churchill,D.; Forwell,L.; Macdonald,G.; Foster,S. (Can Med Assoc J, 2000)